Pfizer Faces Reduced Drug Patent Risks
2 stories
May 29
- STAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and more
statnews.com · May 29
- STAT+: Allogene CEO David Chang stepping down
statnews.com · May 29